CGTX

Cognition Therapeutics, Inc. (CGTX) ESG Analysis Analysis (2026)

Invetso Score: 5.5/10 — Balanced · Last Updated: 2026-09-01

Monthly Update

No material changes this month.

Environmental

Score: 5.2 (Moderate)

CGTX shows limited disclosed environmental intensity data, but its near-zero debt profile suggests less balance-sheet pressure than many peers to fund transition-related capex.

The absence of reported R&D-to-revenue spending in the provided metrics limits evidence of environmental innovation, leaving positioning less transparent than better-disclosed peers.

No material environmental controversies or emissions disclosures were provided, so relative assessment remains neutral rather than advantaged versus peers with clearer sustainability reporting.

Compared with peers that publish detailed climate metrics and targets, CGTX appears less mature in environmental disclosure, which weakens comparability and stakeholder confidence.

Social

Score:

No workforce, safety, or patient-related metrics were provided, so CGTX cannot be shown to outperform peers on core social indicators.

Zero stock-based compensation in the supplied data may indicate lower dilution pressure, but it does not by itself demonstrate stronger employee alignment than peers.

The limited disclosure set reduces visibility into labor practices, diversity, and community impact, leaving CGTX behind peers with more complete social reporting.

Without evidence of social controversies, CGTX avoids a clear peer disadvantage, but the lack of disclosed social programs keeps its positioning only average.

Governance

Score:

CGTX’s very low debt-to-equity ratio suggests conservative capital structure governance, which is generally stronger than more levered peers.

Net debt to EBITDA of about 2.0x indicates manageable leverage, but it is less conservative than peers with net cash or lower leverage.

Zero stock-based compensation in the provided metrics supports cleaner shareholder alignment than peers with heavier equity dilution, improving governance quality.

Overall governance appears somewhat better than average on capital discipline, but limited disclosure on board oversight and controls prevents a stronger peer-relative score.

Overall Score

Score:

CGTX’s ESG positioning is broadly average versus peers, with modest governance strength offset by limited environmental and social disclosure.

Score Driver: Limited ESG Disclosure Relative To Peers

Sources

  • Company filings (10-K, 10-Q, investor presentations)
  • Financial and market data providers
  • Public news and industry information

🔒 Go Beyond This Framework

This is one of 10 institutional-grade frameworks Invetso runs on Cognition Therapeutics, Inc.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

Create your free account on Invetso →